The experiments with these three inhibitors (LCS, MYR, and GW4869) were subsequently repeated including as additional control also infections with a complemented mutant strain, i.e., a derivative of CTL2-cpoS::cat transformed with a plasmid driving expression of CpoS (CTL2-cpoS::cat/pCpoS). This evidence concerns the gene SLC44A2 and infection.